No Detail Found!

Prevalence and comparative analysis of potential drug-drug interactions among hospitalized patients at a tertiary care cardiac institute in Pakistan: Findings from a single centre

Author(s)
Ahmad Ullah Humza National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
Muhammad Asad Akbar National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
Muhammad Asad Bilal Awan National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
Jibran Bin Yousuf National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
Khalid Khan SIHET College of Health Sciences, Swat, Pakistan
Ali Ammar National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan
Abstract
Hospitalized post-operative cardiovascular disease (CVD) patients are often subject to polypharmacy, increasing the risk of potential drug-drug interactions (pDDIs). This observational study assessed 384 post-operative CVD patients for pDDIs using Micromedex Drug-Int® and Lexicomp Interact®. Prevalence, severity, onset, and documentation of pDDIs were analyzed using SPSS 23.0, with logistic regression identifying factors associated with at least two major pDDIs or two pDDIs categorized as X, D, or C. Micromedex Drug-Int® revealed a median of 6.23 pDDIs per patient, with 98.7% of patients having >1 pDDIs. Of 2,389 pDDIs, 64.1% were major. Lexicomp Interact® data showed a median of 7.15 pDDISs per patient, with 99.2% ofpatients having >1 pDDIs. Class C interactions were the most frequent (62.1%), followed by Classes B, D, and X. Additionally, the study identified unique pDDIs from Lexicomp, including Ipratropium-Orphenadrine and Furosemide-Levosulpiride, not listed in Micromedex. The findings highlight the high prevalence of pDDIs in this population, emphasizing the need for regular monitoring. Using pDDI screening tools, clinical pharmacists can be crucial in mitigating these risks, particularly in high-risk patients.
Publication Details
Page(s) 961-968
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Pakistan, Micromedex, Cardiac patient, Polypharmacy, CVD, Lexicomp, Potential drug-drug interactions
0

Citations

0

Downloads

71

Views